Regulation of health products: Striving for best practices
DOI:
https://doi.org/10.11606/issn.2316-9044.v18i2p112-121Keywords:
Brazilian Health Regulatory Agency, Health Regulation.Abstract
The section "Argument" on this issue of the Revista de Direito Sanitário (Journal of Health Law) is again centered on the existing regulatory framework of Brazil in the area of health products. The three articles selected bring an approach with a comparative bias in the different areas in which the Brazilian Health Regulatory Agency (Anvisa) operates: regulation of medical supplies, analysis and registration of pharmaceutical patents and ex post facto control of medicines dangerousness through recall.
Downloads
Downloads
Published
Issue
Section
License
The Revista de Direito Sanitário/ Journal of Health Law adopts the conditions of the Creative Commons Attribution 4.0 Internacional. This license allows to share - "copy and redistribute the material in any medium or format for any purpose, even commercially" and adapt - "remix, transform, and build upon the material for any purpose, even commercially." Details at: https://creativecommons.org/licenses/by/4.0/deed.en